These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15652027)

  • 21. Using betahistine in the treatment of patients with Menière's disease: a meta-analysis with the current randomized-controlled evidence.
    Devantier L; Hougaard D; Händel MN; Liviu-Adelin Guldfred F; Schmidt JH; Djurhuus B; Callesen HE
    Acta Otolaryngol; 2020 Oct; 140(10):845-853. PubMed ID: 32580600
    [No Abstract]   [Full Text] [Related]  

  • 22. The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease.
    Liu JL; Liu JG; Chen XB; Liu YH
    J Laryngol Otol; 2020 Dec; 134(12):1073-1076. PubMed ID: 33280619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term evaluation of the treatment of Menière's disease with betahistine HCl.
    Bertrand RA
    Adv Otorhinolaryngol; 1982; 28():104-10. PubMed ID: 7113814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of betahistine hydrochloride in Méniére's disease.
    Wilmot TJ
    Acta Otolaryngol Suppl; 1972; 305():18-21. PubMed ID: 4353748
    [No Abstract]   [Full Text] [Related]  

  • 25. An agent for the amelioration of vertigo in Ménière's syndrome. Betahistine hydrochloride (Serc).
    JAMA; 1968 Mar; 203(13):1122. PubMed ID: 4966735
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.
    Ganança MM; Caovilla HH; Ganança FF
    Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Ménière's disease in general practice: adherence to the UK National Health Service 'Prodigy' guidelines.
    Smale E; McDonald S; Maha N; Short S
    J Laryngol Otol; 2008 Aug; 122(8):780-5. PubMed ID: 18039416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the efficacy of betahistine in Méniére's syndrome.
    Hommes OR
    Acta Otolaryngol Suppl; 1972; 305():70-9. PubMed ID: 4353751
    [No Abstract]   [Full Text] [Related]  

  • 30. An objective study of the effect of betahistine hydrochloride on hearing and vestibular function tests in patients with Ménière's disease.
    Wilmot TJ
    J Laryngol Otol; 1971 Apr; 85(4):369-73. PubMed ID: 4995451
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasodilators in menière's syndrome.
    Piercy NM
    Br Med J; 1971 Oct; 4(5782):303. PubMed ID: 5001332
    [No Abstract]   [Full Text] [Related]  

  • 32. Vasodilators in Menière's syndrome.
    Tuke JU
    Br Med J; 1971 Nov; 4(5784):431. PubMed ID: 5001364
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-tm treatment of Ménière's disease.
    Elia J
    Int Surg; 1970 Jan; 53(1):24-7. PubMed ID: 4985380
    [No Abstract]   [Full Text] [Related]  

  • 34. Méniére's disease: subjective and objective evaluation of medical treatment with betahistine HCl.
    Bertrand RA
    Acta Otolaryngol Suppl; 1972; 305():48-69. PubMed ID: 4353750
    [No Abstract]   [Full Text] [Related]  

  • 35. [Delirium in a 73-year-old man after many years of unwise use of betahistine].
    Hoenders HJ; Wilterdink J
    Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2338-41. PubMed ID: 15587054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic results of betahistine on Meniere's disease. Multi-variable analysis of the results of the double blind test and Fisher's evaluation method].
    Okamoto K; Hazeyama F; Taira T; Yoshida A; Onoda T
    Iryo; 1968 May; 22(5):650-66. PubMed ID: 4972506
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of peripheral vestibular vertigo with betahistine dimesilate (Aequamen)].
    Reker U
    MMW Munch Med Wochenschr; 1983 Oct; 125(41):915-8. PubMed ID: 6417495
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug information. Therapeutic main group: agents for the treatment of dizziness--betahistine].
    Lumholtz IB
    Sygeplejersken; 1979 Mar; 79(12):28. PubMed ID: 254983
    [No Abstract]   [Full Text] [Related]  

  • 39. [Not Available].
    Ernst A; Schlattmann P; Waldfahrer F; Westhofen M
    Laryngorhinootologie; 2017 Aug; 96(8):519-521. PubMed ID: 28850992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term office treatment of Meniere's disease.
    Martins JK
    Eye Ear Nose Throat Mon; 1969 Jul; 48(7):410-2. PubMed ID: 4978414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.